Eldelumab
Eldelumab is a monoclonal antibody designed for the treatment of autoimmune diseases. It was developed by MedImmune, a subsidiary of AstraZeneca. Eldelumab works by targeting and inhibiting the interleukin-7 receptor, a protein that plays a crucial role in the immune response.
Mechanism of Action[edit]
Eldelumab is a monoclonal antibody that binds to the interleukin-7 receptor (IL-7R). The IL-7R is a protein found on the surface of certain immune cells, including T cells and B cells. By binding to this receptor, eldelumab prevents the binding of interleukin-7, a cytokine that promotes the survival and proliferation of these immune cells. This inhibition reduces the immune response, which can be beneficial in the treatment of autoimmune diseases.
Clinical Trials[edit]
Eldelumab has been tested in several clinical trials for its efficacy in treating various autoimmune diseases. In a Phase II trial for moderate to severe ulcerative colitis, eldelumab showed a significant reduction in disease activity compared to placebo. However, further studies are needed to confirm these results and determine the optimal dosing regimen.
Side Effects[edit]
As with all medications, eldelumab can cause side effects. The most common side effects reported in clinical trials include nausea, headache, and fatigue. Serious side effects can include infections due to the suppression of the immune system. Patients should discuss potential side effects with their healthcare provider before starting treatment with eldelumab.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
